OR11L1: A GPCR Involved in Olfactory Perception and Potential Drug Target
OR11L1: A GPCR Involved in Olfactory Perception and Potential Drug Target
OR11L1 (Olfactory Receptor OR1-50) is a protein that is expressed in the olfactory system, which is responsible for the sense of smell. OR11L1 is a G protein-coupled receptor (GPCR), which is a family of transmembrane proteins that play an important role in sensory perception. GPCRs are involved in the transmission of sensory information from the sensory neurons to the brain.
OR11L1 is a key protein in the olfactory system, as it is involved in the perception of olfactory input. It is expressed in the olfactory neurons, which are the neurons that carry the olfactory information from the olfactory organs (such as the nose, mouth, and throat) to the brain. OR11L1 is also expressed in the supporting cells of the olfactory system, which provide structural support to the olfactory neurons.
OR11L1 is a member of the OR family of GPCRs, which includes several other proteins that are involved in sensory perception. The OR family is characterized by the presence of a unique extracellular domain that is involved in the regulation of gene expression. This domain is known as the transcription factor binding domain (TFB domain) and is responsible for the interaction with GPCR-specific transcription factors.
OR11L1 is expressed in many different tissues and cells in the body, including the brain, heart, and pancreas. It is also involved in several different signaling pathways, including the regulation of cell proliferation and differentiation, as well as the regulation of sensory perception.
One of the most promising aspects of OR11L1 is its potential as a drug target. Researchers are interested in using OR11L1 as a therapeutic agent to treat various neurological and psychiatric disorders, such as Alzheimer's disease, Parkinson's disease, and sensory disorders.
OR11L1 has also been identified as a potential biomarker for several neurological disorders. For example, it has been shown to be involved in the regulation of neurogenesis, which is the process by which new neurons are generated in the brain. This suggests that OR11L1 may be involved in the development and progression of certain neurological disorders.
In addition to its potential therapeutic and biomarker applications, OR11L1 is also of interest to researchers because of its unique structure and function. The TFB domain is a highly conserved region that is found in many different GPCRs, but the specific combination of amino acids in this domain is unique. This makes OR11L1 a valuable study object for researchers who are interested in the mechanisms of GPCR function.
Summary: OR11L1 (Olfactory Receptor OR1-50) is a protein that is expressed in the olfactory system, which is responsible for the sense of smell. OR11L1 is a G protein-coupled receptor (GPCR), which is a family of transmembrane proteins that play an important role in sensory perception. GPCRs are involved in the transmission of sensory information from the sensory neurons to the brain. OR11L1 is a key protein in the olfactory system, as it is involved in the perception of olfactory input. It is also expressed in the supporting cells of the olfactory system, which provide structural support to the olfactory neurons. OR11L1 is a member of the OR family of GPCRs, which includes several other proteins that are involved in sensory perception. The OR family is characterized by the presence of a unique extracellular domain that is involved in the regulation of gene expression. This domain is known as the transcription factor binding domain (T
Protein Name: Olfactory Receptor Family 11 Subfamily L Member 1
Functions: Odorant receptor
The "OR11L1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR11L1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P
